Create Alert
Watchlist

Natco Pharma

₹841.25
-23.55 (2.72%) 1D
NSE
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this

Performance

Open
855.50
Prev. Close
864.80
Volume
9,77,040
Total traded value
82.19 Cr
Upper Circuit
1,009.50
Lower Circuit
673.00

Fundamentals

Market Cap₹15,482Cr
ROE17.79%
P/E Ratio(TTM)10.08
EPS(TTM)85.79
P/B Ratio1.79
Dividend Yield0.69%
Industry P/E33.01
Book Value482.93
Debt to Equity0.03
Face Value2
Understand Fundamentals

Financials

*All values are in Rs. Cr
No Graph Data To Display
Quarterly
Yearly

About Natco Pharma

Powered by decades of experience, Natco Pharma is a leading pharmaceutical company with a vertically integrated business model, focusing on strong R&D to develop high-potential medicines. The company's core mission is to make specialty medicines accessible to all, which guides its business strategies and commitment to providing affordable healthcare solutions globally. It operates by developing, manufacturing, and marketing finished dosage formulations (FDF), active pharmaceutical ingredients (APIs), and intermediate products for domestic and international markets. Leveraging its expertise, the company has also strategically expanded its business into the Crop Health Sciences division to provide innovative crop solutions to farmers. Natco has a strong presence in the domestic market with 9 of its brands achieving sales of over ₹100 million each, reaching 60,000 doctors nationwide.;
Parent OrganisationNatco Pharma Limited
Managing DirectorRajeev Nannapaneni
NSE SymbolNATCOPHARM

Shareholding Pattern

Sep '24
Dec '24
Mar '25
Jun '25
Sep '25
Promoters
49.48%
Retail And Others
30.56%
Foreign Institutions
14.09%
Other Domestic Institutions
3.68%
Mutual Funds
2.20%

Similar Stocks

COMPANY
52 WEEK
MARKET PRICE
P/E Ratio
JB Chemicals & Pharmaceuticals
NA
(0.00%)
37.64
Emcure Pharmaceuticals
NA
(0.00%)
31.38
Cohance Lifesciences
NA
(0.00%)
71.87
Wockhardt
NA
(0.00%)
-417.83